A Space for Mystery Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
Full-Dose Anticoagulation Again Favored for COVID Admissions Despite failures, FREEDOM trial supports mortality advantage in general ward use Mar 07, 2023
KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Combo Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
Cases of Breast Implant-Associated Lymphoma Continue to Accumulate More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
Antibody-Drug Conjugates Take Breast Cancer Field by Storm Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant Randomized study finds no benefit with 12 months of nicotinamide versus placebo Mar 01, 2023
'Alarming' Rise in Colon Cancer Rates Among Younger People Rate doubled in under-50 age group since 1995, concerning trend toward more advanced disease Mar 01, 2023
How to Make Meaningful Moves Toward Health Equity in Cancer Care Addressing the three R's: resources, research, and racism Feb 27, 2023
Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe News, features, and commentary about cancer-related issues Feb 24, 2023
Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Years Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years Feb 23, 2023
ICI/TKI Combo Maintains Survival Benefit in Advanced RCC Updated trial data show nivolumab/cabozantinib doublet "is getting better with age" Feb 20, 2023
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancer Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancer Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALL Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL? Feb 16, 2023
If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer? Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patients Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market New book by former Forbes senior editor pulls back the curtain on drug development Feb 13, 2023
FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancer Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
AI Tool Forecasts Lung Cancer Risk From a Single CT Scan Experts give high marks to performance of "Sybil" in predicting disease over 6 years Feb 07, 2023
Risk Model-Based Lung Cancer Screening More Cost-Effective Than USPSTF Recs Risk prediction models more sensitive than age-, smoking history-based methods Feb 07, 2023
Patients' Defensive Thinking May Hinder Colorectal Cancer Screening Study explored why people refused at-home stool test Feb 06, 2023
Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma Researchers say safety, efficacy of ALLO-715 comparable to autologous anti-BCMA products Feb 02, 2023
Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancer A majority of patients obtained disease control with tarlatamab; responses proved durable Feb 01, 2023
FDA Greenlights First Drug for ESR1-Mutated Breast Cancer Elacestrant almost doubled PFS versus standard endocrine therapy in advanced ER+/HER2- disease Jan 30, 2023
Immunotherapy Survival Gains 'Less Impressive' in Older Lung Cancer Patients Study finds median OS improvement of just 1 month for patients 75 and older Jan 26, 2023
MDM2 Inhibitor Breaks Through in Trial of Liposarcoma, Other Advanced Malignancies Intermittent dosing dramatically reduced myelosuppression that has hindered drug class Jan 26, 2023
New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia A Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77% Jan 25, 2023
Inflammatory VEXAS Syndrome May Not Be So Uncommon Is new disease being missed by physicians? Jan 24, 2023
Neoadjuvant Chemo Reduces Disease Recurrence in Operable Colon Cancer Consider it now "an option" for locally advanced disease, editorialists say Jan 24, 2023
